SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Goodyear Tire & Rubber Co. engages in the development, manufacture, distribution, and sale of tires. It operates through the following geographical segments: Americas, Europe, Middle East, and Africa, and Asia Pacific. The Americas segment is involved in the development, manufacture, distribution, and sale of tires and related products and services in North, Central, and South America. The Europe, Middle East, and Africa segment focuses on the development, manufacture, distribution, and sale of tires for automobiles, trucks, buses, aircraft, motorcycles, earthmoving, mining, and industrial equipment throughout Europe, the Middle East, and Africa. The Asia Pacific segment refers to the development, manufacture, distribution, and sales of tires for automobiles, trucks, buses, aircraft, farm, earthmoving, mining, and industrial equipment throughout the Asia Pacific region. The company was founded by Frank A. Seiberling on August 29, 1898 and is headquartered in Akron, OH.

Goodyear Tire & Rubber Co.

Goodyear Tire & Rubber is currently the subject of heavy community debate as investors weigh its deeply undervalued status and long-term turnaround efforts against ongoing concerns about high debt levels and operational restructuring. While some market participants are betting on a recovery driven by high demand for tire replacements and a potential takeover, others remain skeptical due to volatility and consistent downward price pressure.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

GameStop is trending following an unsolicited fifty-six billion dollar acquisition bid for eBay, a move that has sparked intense debate among investors regarding the viability of such a highly leveraged acquisition. Community members are actively split, with some viewing the move as a visionary corporate chess play, while critics, including high-profile investors, have voiced significant concerns over the proposed debt levels and potential share dilution.

Conagra Brands, Inc. engages in the manufacture and sale of processed and packaged foods. It operates through the following segments: Grocery and Snacks, Refrigerated and Frozen, International, and Foodservice. The Grocery and Snacks segment includes branded, and shelf stable food products sold in various retail channels in the United States. The Refrigerated and Frozen segment is composed of branded, and temperature-controlled food products sold in various retail channels in the United States. The International segment offers branded food products in various temperature states, sold in various retail and foodservice channels outside of the United States. The Foodservice segment focuses on branded and customized food products, including meals, entrees, sauces, and a variety of custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The company was founded by Alva Kinney and Frank Little in 1919 and is headquartered in Chicago, IL.

Conagra Brands Inc

Conagra Brands is experiencing significant selling pressure amid broader packaged food sector downgrades and analyst concerns over earnings visibility and dividend sustainability. While sentiment remains bearish, community members are actively debating whether the stock's multi-year price lows present a contrarian long-term value opportunity or a potential yield trap.

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Kazia Therapeutics Limited - ADR

Kazia Therapeutics

Kazia Therapeutics is generating significant investor interest following a recent private placement of $50 million, which strengthens its balance sheet through 2028 and addresses Nasdaq compliance concerns. The market is closely monitoring upcoming clinical data readouts for its lead asset, paxalisib, particularly in triple-negative breast cancer and combination therapies, with community discussions heavily focused on potential buyout interest and the company's strong regulatory portfolio.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as institutional interest remains high, highlighted by the strong performance of Bitwise's XRP ETF and increasing institutional adoption of the XRP Ledger for real-world asset tokenization. Community sentiment is deeply split, with investors actively debating the potential impact of ongoing regulatory developments like the Clarity Act against concerns regarding Ripple's circulating supply and long-term price suppression.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit Inc. is trending as investors react to strong technical momentum and speculation regarding potential S&P 500 inclusion, even as the stock grapples with volatility and mixed sentiment around its valuation. The community remains deeply divided, with some highlighting the company's robust data moat and advertising growth as bullish catalysts, while skeptics point to technical resistance levels and broader market pressure on the software sector.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

Oatly is experiencing significant investor attention driven by speculation surrounding a potential strategic carve-out of its China operations and the company's recent shift toward profitable growth. Community discussion is heavily focused on the stock's low valuation relative to its brand reach, the anticipation of new product launches in the US, and the belief that JAB Holding's increased stake signals a long-term turnaround or acquisition play.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant institutional accumulation as investors position themselves ahead of major clinical readouts, including the upcoming 52-week data for its sonelokimab program. The community is focused on this data and the Goldman Sachs conference, with many speculating that these events could serve as the catalyst for an acquisition or a significant upward repricing.

The Mosaic Co. engages in the production and marketing of concentrated phosphate and potash crop nutrients. It operates through the following segments: Phosphates, Potash, and Mosaic Fertilizantes. The Phosphates segment is involved in the ownership and operation of mines and production facilities which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants which produce concentrated phosphate crop nutrients. The Potash segment includes mining, processing, and selling potash. The Mosaic Fertilizantes segment focuses on mines, chemical plants, crop nutrient blending and bagging facilities, port terminals, and warehouses. The company was founded on March 25, 2004 and is headquartered in Tampa, FL.

Mosaic Company

Mosaic Company is trending as investors weigh the stock's significant discount to book value against the volatile input cost environment caused by the ongoing Strait of Hormuz supply disruptions. The community is actively debating whether the stock is a long-term value opportunity that will benefit from tightening global fertilizer supplies or if it remains a risky play due to its sensitivity to rising raw material prices.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is attracting intense community attention as retail investors analyze the company's evolving commercial landscape, particularly the data regarding Tonmya prescription trends and insurance access. While sentiment remains polarized due to ongoing dilution concerns and the leadership of CEO Seth Lederman, community discussions are heavily focused on tracking the company's prescription growth as a primary catalyst for potential valuation improvement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It PR Newswire NEW YORK, May 22, 2026 Issued on behalf of Conexeu Sciences Inc.Companies mentioned: Conexeu Sciences Inc. (NASDAQ...

Evolus to Participate in The Jefferies Global Healthcare Conference

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a...

Evolus Announces Commercial Launch of Estyme Injectable Hyaluronic Acid Gels in Europe

Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the commercial launch of Estyme (pronounced...

Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates

Evolus (EOLS) delivered earnings and revenue surprises of +25.93% and +0.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Evolus Q1 Earnings Call Highlights

Evolus (NASDAQ:EOLS) reported first-quarter results that management said reflected a stronger operating model following cost structure changes implemented last year, while reiterating its full-year...

Evolus (EOLS) Q2 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Evolus (NASDAQ:EOLS) Releases Earnings Results, Misses Expectations By $0.02 EPS

Evolus (NASDAQ:EOLS - Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The business had revenue of $73.14 million for the quarter, compared to analyst estimates of $72.52 million...

Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook

Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial results for the first quarter ended...

Evolus (EOLS) to Release Quarterly Earnings on Monday

Evolus (NASDAQ:EOLS) will be releasing its Q1 2026 earnings after the market closes on Monday, May 4. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-4-evolus-inc-stock...

Evolus, Inc. (NASDAQ:EOLS) Given Consensus Rating of "Moderate Buy" by Analysts

Evolus, Inc. (NASDAQ:EOLS - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommenda...

Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.

EOLSEvolus Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EOLS News